Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1975 Jun;59(6):301–303. doi: 10.1136/bjo.59.6.301

Effect of pindolol on intraocular pressure.

I Bonomi, P Steindler
PMCID: PMC1042625  PMID: 1100097

Abstract

Pindolol, a strong beta-adrenergic blocking agent, instilled into the conjunctival sac of normal and glaucomatous eyes, produced a significant drop in intraocular pressure. This was not, at first, accompanied by any variation in outflow facility; only after prolonged treatment did an increase in facility appear, which accounted only for one-third of the tension-lowering effect. The drug was well tolerated, and did not affect either pupil motility or corneal sensitivity. It seems suitable for a trial use in the treatment of glaucoma.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BONOMI L. SULL'AZIONE DI DUE SOSTANZE AD ATTIVITA BETA-SIMPATICOLITICA SULLA PRESSIONE INTRAOCULARE DEL CONIGLIO. Boll Ocul. 1964 Jun;43:440–447. [PubMed] [Google Scholar]
  2. Clark B., Saameli K. Pharmacological properties of a new beta-receptor blocking agent. Triangle. 1970;9(8):300–308. [PubMed] [Google Scholar]
  3. Coté G., Drance S. M. The effect of propranolol on human intraocular pressure. Can J Ophthalmol. 1968 Jul;3(3):207–212. [PubMed] [Google Scholar]
  4. Hill R. C., Turner P. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969 Jun;36(2):368–372. doi: 10.1111/j.1476-5381.1969.tb09511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lubawski I., Wale J. Studies with LB 46, a new beta-receptor blocking drug. Eur J Pharmacol. 1969;6(3):345–348. doi: 10.1016/0014-2999(69)90195-2. [DOI] [PubMed] [Google Scholar]
  6. Musini A., Fabbri B., Bergamaschi M., Mandelli V., Shanks R. G. Comparison of the effect of propranolol, lignocaine, and other drugs on normal and raised intraocular pressure in man. Am J Ophthalmol. 1971 Oct;72(4):773–781. doi: 10.1016/0002-9394(71)90017-1. [DOI] [PubMed] [Google Scholar]
  7. Phillips C. I., Howitt G., Rowlands D. J. Propranolol as ocular hypotensive agent. Br J Ophthalmol. 1967 Apr;51(4):222–226. doi: 10.1136/bjo.51.4.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Takáts I., Szilvássy I., Kerek A. Intraocularer Druck und Kammerwasserzirkulations-Untersuchungen an Kaninchenaugen nach intravenöser Verabreichung von Propranolol (Inderal. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1972;185(4):331–342. doi: 10.1007/BF00410765. [DOI] [PubMed] [Google Scholar]
  9. Vale J., Phillips C. I. Effect of DL- and D-propranolol on oscular tension in rabbits and patients. Exp Eye Res. 1970 Jan;9(1):82–90. doi: 10.1016/s0014-4835(70)80061-6. [DOI] [PubMed] [Google Scholar]
  10. Virno M., Giraldi J. P., Marinosci F., Missiroli A. Indagine sul meccanismo d'azione di due agenti ipotensivi endoculari: l'ergotamina e il propanololo. Boll Ocul. 1969 Dec;48(12):907–919. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES